Amrize Forecast, price target & analysts
$48.71
1.04%
yesterday
NYSE,
Oct 03, 10:00 pm CET
Amrize Target price 2025 - Analyst rating & recommendation
Powered by
Amrize Classifications & Recommendation:
Buy
82%
Hold
18%
Amrize Price Target
| Target Price | $49.05 |
| Price | $48.72 |
| Potential | 0.68% |
| Number of Estimates | 6 |
| 6 Analysts have issued a price target Amrize 2026 . The average Amrize target price is $49.05. This is 0.68% higher than the current stock price. The highest price target is $52.50 7.76% , the lowest is $32.57 33.14% . | |
| A rating was issued by 11 analysts: 9 Analysts recommend Amrize to buy, 2 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Amrize stock has an average upside potential 2026 of 0.68% . Most analysts recommend the Amrize stock at Purchase. |
Current Amrize Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| JEFFERIES |
Hold
➜
Hold
|
Unchanged | Aug 28 2025 |
| B of A Securities |
➜
Neutral
|
Initiated | Jun 26 2025 |
| Morgan Stanley |
➜
Overweight
|
Initiated | Jun 24 2025 |
| RBC Capital |
➜
Outperform
|
Initiated | Jun 24 2025 |
| Truist Securities |
➜
Buy
|
Initiated | Jun 24 2025 |
| UBS |
➜
Neutral
|
Initiated | Jun 24 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
JEFFERIES:
Hold
➜
Hold
|
Aug 28 2025 |
|
Initiated
B of A Securities:
➜
Neutral
|
Jun 26 2025 |
|
Initiated
Morgan Stanley:
➜
Overweight
|
Jun 24 2025 |
|
Initiated
RBC Capital:
➜
Outperform
|
Jun 24 2025 |
|
Initiated
Truist Securities:
➜
Buy
|
Jun 24 2025 |
|
Initiated
UBS:
➜
Neutral
|
Jun 24 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
